UNC0379

UNC0379 Basic information
Product Name:UNC0379
Synonyms:UNC0379;6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine;6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine UNC0379;UNC0379, >=98%;UNC03;6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-4-quinazolinamine;UNC0379, UNC-0379, UNC 0379;UNC 0379; UNC-0379
CAS:1620401-82-2
MF:C23H35N5O2
MW:413.56
EINECS:
Product Categories:Inhibitors
Mol File:1620401-82-2.mol
UNC0379 Structure
UNC0379 Chemical Properties
Boiling point 606.3±65.0 °C(Predicted)
density 1.168±0.06 g/cm3(Predicted)
storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
solubility Soluble in DMSO (up to 30 mg/ml)
form solid
pka10.54±0.20(Predicted)
color Tan
Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
Safety Information
MSDS Information
UNC0379 Usage And Synthesis
DescriptionUNC0379 (CAS 1620401-82-2) is an inhibitor of the lysine methyltransferase SETD8 with selectivity over 15 other methyltransferases.1 IC50’s = 7.3 μM in a radioactive methyl transfer assay and 9.0 μM in an MCE assay. UNC0379 treatment of SY5Y and NGP neuroblastoma cell lines lead to activation of p53 and decreased tumor growth in an ex-vivo tumorigenicity assay.2
References1) Ma et al. (2014), Discovery of a Selective, Substrate-Competitive Inhibitor of the Lysine Methyltransferase SETD8; J. Med. Chem. 57 6822 2) Veschi et al. (2017), Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma; Cancer Cell 31 50
UNC0379 Preparation Products And Raw materials
UNC 1999 UNC 0631 UNC-0642 UNC0638 UNC2025 SGC0946 GDC-0152 Paclitaxel NUC-7738 UNC0646 UNC569 UNC-926 Hydochloride UNC-1215 GO 6983 TG101209 Y27632 (hydrochloride) UNC2250 UNC 669

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.